Stribild is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Elvitegravir; Cobicistat; Emtricitabine; Tenofovir Disoproxil Fumarate.
| Product ID | 70518-0674_6991caf2-bee9-e25a-e053-2991aa0ae32b | 
| NDC | 70518-0674 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Stribild | 
| Generic Name | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2017-08-21 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA203100 | 
| Labeler Name | REMEDYREPACK INC. | 
| Substance Name | ELVITEGRAVIR; COBICISTAT; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 
| Active Ingredient Strength | 150 mg/1; mg/1; mg/1; mg/1 | 
| Pharm Classes | HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2019-12-31 | 
| Marketing Start Date | 2017-08-21 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA203100 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2017-08-16 | 
| Marketing End Date | 2020-05-01 | 
| Ingredient | Strength | 
|---|---|
| ELVITEGRAVIR | 150 mg/1 | 
| SPL SET ID: | 4699d50c-fce5-4b6f-a86a-6bf4eb29c5b3 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 50090-1318 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 
| 53808-0887 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 
| 61958-1201 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 
| 69189-1201 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 
| 70518-0674 | Stribild | elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  STRIBILD  85688699  4320307 Live/Registered | GILEAD SCIENCES IRELAND UC 2012-07-27 | 
|  STRIBILD  85555217  4263613 Live/Registered | GILEAD SCIENCES IRELAND UC 2012-02-28 |